Location History:
- Chicago, IL (US) (1977 - 1981)
- Dune Acres, IN (US) (1985)
- Woodhaven, NY (US) (1989)
- Carlsbad, CA (US) (1999)
- Holbrook, MA (US) (2004 - 2024)
Company Filing History:
Years Active: 1977-2024
Title: The Innovative Mind of John J Flanagan
Introduction
John J Flanagan is a prominent inventor based in Chicago, IL, known for his contributions to the field of polymerase chain reaction technology. With a total of 13 patents to his name, Flanagan has demonstrated a remarkable ability to innovate and improve devices and systems that enhance scientific research and diagnostics.
Latest Patents
Among his latest inventions, Flanagan developed devices for real-time polymerase chain reaction that represent significant advancements in the field. His improved devices and systems incorporate a light source, detector, waveguide, and filters designed to occupy minimal space. These innovations facilitate the detection of stationary samples, significantly reduce sample read time, and allow for the simultaneous reading of multiple light wavelengths, enhancing the efficiency and effectiveness of the polymerase chain reaction process.
Career Highlights
Throughout his career, John J Flanagan has worked with various organizations, most notably Streck, Inc. His experience in these roles has enabled him to apply his ingenuity to create solutions that push the boundaries of current technologies in molecular biology.
Collaborations
Flanagan has collaborated with notable individuals in his field, including Matthew R Kreifels and Scott E Whitney. These partnerships have likely contributed to the success of his innovations, facilitating the exchange of ideas and expertise that enhance their respective works.
Conclusion
John J Flanagan's work exemplifies the spirit of innovation that drives advancements in scientific technologies. With his extensive patent portfolio and collaborative spirit, he continues to make an impactful contribution to the field of polymerase chain reaction technology, paving the way for future breakthroughs.